Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Phase 2 Interventional

Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients

ClinicalTrials.gov ID: NCT06126380

Public ClinicalTrials.gov record NCT06126380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 10:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AT-1501-K209: BESTOW-EXTENSION: A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the long term safety and efficacy of AT-1501 (tegoprubart) compared with tacrolimus in patients undergoing kidney transplantation.

Study identification

NCT ID
NCT06126380
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eledon Pharmaceuticals
Industry
Enrollment
132 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 25, 2023 (Actual)
Primary completion
Dec 2029 (Estimated)
Completion
Dec 2029 (Estimated)
Last update posted
Dec 10, 2025

2023 – 2029

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
25
Facility City State ZIP Site status
University of California Los Angeles Los Angeles California 90024 —
Keck School of Medicine of USC Los Angeles California 90033 —
University of California, Irvine Medical Center Orange California 92868 —
University of California, Davis Medical Center Sacramento California 95817 —
Jacobs Medical Center at UC San Diego Health San Diego California 92037 —
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Tampa General Hospital Tampa Florida 33606 —
Emory University Hospital Atlanta Georgia 30322 —
Augusta University Augusta Georgia 30912 —
University of Chicago Chicago Illinois 60637 —
Loyola University Medical Center Maywood Illinois 60153 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Tulane Medical Center New Orleans Louisiana 70112 —
John Hopkins University Baltimore Maryland 21287 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Henry Ford Health System Detroit Michigan 48202 —
University of Minnesota Medical Center Minneapolis Minnesota 55455 —
Mayo Clinic Rochester Minnesota 55907 —
Washington University in St. Louis St Louis Missouri 63110 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
New York University Langone Health - Tisch Hospital New York New York 10016 —
Duke University Medical Center Durham North Carolina 27710 —
University of Cincinnati Medical Center Cincinnati Ohio 45219 —
University of Pittsburgh Medical Center Harrisburg Pennsylvania 17104 —
UT Southwestern Dallas Texas 75235 —
Virginia Commonwealth University Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06126380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 10, 2025 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06126380 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →